Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herling

Showing results (451-460 of 481) with videos related to

Pageof 49
Sort By:
Blood Advances|March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval labelKiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.
Blood|September 30, 2022
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLLJohanna Stachelscheid, Qu Jiang, Christoph Aszyk, et al.
Cancer Research|October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic DiscoveryAleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Leukemia|February 12, 2020
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study groupManuela A Hoechstetter, Raymonde Busch, Barbara Eichhorst, et al.
Leukemia|February 20, 2020
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trialCarmen D Herling, Florence Cymbalista, Carolin Groß-Ophoff-Müller, et al.
Blood Cancer Discovery|October 23, 2024
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple MyelomaDavid Fandrei, Sabine Seiffert, Michael Rade, et al.
American Journal of Hematology|September 12, 2025
Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging ConceptsPeter Valent, Johann Wojta, Petri T Kovanen, et al.
Leukemia|January 6, 2024
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myelomaLuise Fischer, Nora Grieb, Patrick Born, et al.
Nutrients|April 13, 2023
Fish Oil Supplementation Improves the Repeated-Bout Effect and Redox Balance in 20-30-Year-Old Men Submitted to Strength TrainingGustavo Barquilha, Cesar Miguel Momesso Dos Santos, Kim Guimaraes Caçula, et al.
Pageof 49

Showing results (451-460 of 481) with videos related to

Sort By:
Pageof 49
Blood Advances|March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval labelKiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.
Blood|September 30, 2022
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLLJohanna Stachelscheid, Qu Jiang, Christoph Aszyk, et al.
Cancer Research|October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic DiscoveryAleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Leukemia|February 12, 2020
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study groupManuela A Hoechstetter, Raymonde Busch, Barbara Eichhorst, et al.
Leukemia|February 20, 2020
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trialCarmen D Herling, Florence Cymbalista, Carolin Groß-Ophoff-Müller, et al.
Blood Cancer Discovery|October 23, 2024
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple MyelomaDavid Fandrei, Sabine Seiffert, Michael Rade, et al.
American Journal of Hematology|September 12, 2025
Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging ConceptsPeter Valent, Johann Wojta, Petri T Kovanen, et al.
Leukemia|January 6, 2024
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myelomaLuise Fischer, Nora Grieb, Patrick Born, et al.
Nutrients|April 13, 2023
Fish Oil Supplementation Improves the Repeated-Bout Effect and Redox Balance in 20-30-Year-Old Men Submitted to Strength TrainingGustavo Barquilha, Cesar Miguel Momesso Dos Santos, Kim Guimaraes Caçula, et al.
Pageof 49